Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Connection between depression and osteoporosis

31.10.2006
Depression can cause a loss of bone mass, leading to osteoporosis and fractures, say researchers at the Hebrew University of Jerusalem.

The researchers say their findings constitute a significant step forward in understanding the interaction between the mind and the skeletal system. Based on their findings, the researchers have already been able to demonstrate the efficacy of anti-depressant drugs in preventing bone mass loss.

The findings of the Hebrew University researchers are being published this week in the American journal PNAS (Proceedings of the National Academy of Sciences).

Participants in the project were researchers from the university’s Brain and Behavior Laboratory, headed by Prof. Raz Yirmia; from the Bone Laboratory, headed by Prof. Itai Bab; and from the Brain Trauma Laboratory, headed by Prof. Esther Shohami. Also participating were doctoral students Inbal Goshen, Alon Bajayo , Tirza Kreisel, Sharon Feldman and Yosef Tam

Loss of bone mass is the leading cause of osteoporosis and bone fractures among the aged in general and among post-menopausal women in particular. Several studies indicate that people with major depression generally have a lower bone mass density compared to control samples; however, no direct link between these two conditions has been established.

In order to examine the connection between depression and bone mass loss, the researchers used a model involving laboratory mice. Following the induction of a depression-like condition, the mice developed behavioral symptoms mirroring those seen in depressed humans, including a reduction in pleasurable activity and in social interaction.

After four weeks in a depressed state, the laboratory animals showed a dramatic bone mass loss, including in the hip bone and vertebrae. This loss was caused by impairment in the bone renewal process, which is essential to maintaining normal bone density. This impairment was caused by a reduction in the number of bone-building cells, which are called osteoblasts.

The laboratory tests showed that chronic use of an anti-depressant drug halted not only the depression itself but also the loss of bone density.

The researchers were also able to describe the process connecting depression to the skeletal structure. They found that depression sets off a neural system connecting the brain to the internal organs, including the skeleton. This system is called the “sympathetic nervous system.” Its activation causes the secretion within the bone of a chemical compound called noradrenaline, which has a detrimental effect on the bone-building cells. The researchers were able to show that chronic treatment with a drug that blocks noradrenaline in the bone also blocks the detrimental influence of depression on the bone.

This research serves as the basis for new, efficient drugs for treatment of osteoporosis, which is the most prevalent degenerative disease in western society. The Hebrew University’s technology transfer company, Yissum, has applied for a patent for treatment of osteoporosis through anti-depressants.

“The connection between the brain and the skeleton in general, and the influence of depression on bone mass in particular is a new area of research about which we still know very little,” said Prof. Yirmiya. “The new findings, which we have discovered in the Hebrew University laboratories, point for the first time to depression as an important element in causing bone mass loss and osteoporosis.”

Prof. Bab said that “together with other research which we have published in the past year, we have developed a new area of research that we call ‘neuro-psycho-osteology,’ which deals with the connection between the brain, mental states and the skeleton.”

The research at the Hebrew University was carried out with funding from the Bikura program of the Israel National Science Foundation.

Jerry Barach | alfa
Further information:
http://www.huji.ac.il

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>